BioCentury | May 20, 2002
Financial News

MicroChips raises $16 million

...in a Series B round. Investors, led by IDG Ventures, included Polaris Venture; Care Capital; Boston University Community Technology Fund...
BioCentury | Jun 18, 2001
Finance

Ebb & Flow

If many U.K. investors won't pony up enough money to allow well-capitalized drug development, Cyclacel isn't going to go hat-in-hand trying to explain why it needs more. Instead, the company has chosen to go to...
BioCentury | Jun 18, 2001
Finance

Ebb & Flow

If many U.K. investors won't pony up enough money to allow well-capitalized drug development, Cyclacel isn't going to go hat-in-hand trying to explain why it needs more. Instead, the company has chosen to go to...
BioCentury | Jun 14, 2001
Financial News

NitroMed raises $31.4 million

NitroMed (Bedford, Mass.) raised $31.4 million in a private financing. NitroMed said the money will be used to continue its A-HeFT study, which is designed to confirm the efficacy of its BiDil to treat CHF...
BioCentury | Apr 10, 2000
Financial News

Exact Laboratories raises $32 million

...Greylock Management; Highland Capital Partners; RS Investment Management; Mayo Foundation for Medical Education and Research; Boston University Community Technology Fund...
Items per page:
1 - 5 of 5
BioCentury | May 20, 2002
Financial News

MicroChips raises $16 million

...in a Series B round. Investors, led by IDG Ventures, included Polaris Venture; Care Capital; Boston University Community Technology Fund...
BioCentury | Jun 18, 2001
Finance

Ebb & Flow

If many U.K. investors won't pony up enough money to allow well-capitalized drug development, Cyclacel isn't going to go hat-in-hand trying to explain why it needs more. Instead, the company has chosen to go to...
BioCentury | Jun 18, 2001
Finance

Ebb & Flow

If many U.K. investors won't pony up enough money to allow well-capitalized drug development, Cyclacel isn't going to go hat-in-hand trying to explain why it needs more. Instead, the company has chosen to go to...
BioCentury | Jun 14, 2001
Financial News

NitroMed raises $31.4 million

NitroMed (Bedford, Mass.) raised $31.4 million in a private financing. NitroMed said the money will be used to continue its A-HeFT study, which is designed to confirm the efficacy of its BiDil to treat CHF...
BioCentury | Apr 10, 2000
Financial News

Exact Laboratories raises $32 million

...Greylock Management; Highland Capital Partners; RS Investment Management; Mayo Foundation for Medical Education and Research; Boston University Community Technology Fund...
Items per page:
1 - 5 of 5